<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hypo- and <z:mp ids='MP_0002318'>hypercapnia</z:mp> produced in dogs had no effect on the level of endogenous <z:chebi fb="11" ids="26333">prostaglandin</z:chebi>-like substances (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PLS</z:e>) bioassayed continuously in sagittal sinus blood </plain></SENT>
<SENT sid="1" pm="."><plain>Increased release of endogenous <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PLS</z:e>, predominantly of <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E-like substance into cerebral venous blood occurred in conditions injurious to brain, such as <z:mp ids='MP_0005039'>hypoxia</z:mp> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and embolism </plain></SENT>
<SENT sid="2" pm="."><plain>It may be concluded that increased output of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PLS</z:e> into cerebral venous blood is not related to functional changes in cerebral blood flow, but results from cerebral and/or cerebrovascular damage </plain></SENT>
<SENT sid="3" pm="."><plain>Enchanced generation of endogenous <z:chebi fb="11" ids="26333">prostaglandins</z:chebi> and their release into cerebral venous blood preceed the development of structural alterations evoked by <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in brain </plain></SENT>
</text></document>